Cargando…
Enasidenib‐induced Sweet syndrome with differentiation syndrome
Multiple conditions such as drug rash, thromboembolism, sepsis, and heart failure can mimic differentiation syndrome; therefore, maintaining a high index of suspicion is important, as the prognosis is usually good if adequately treated.
Autor principal: | Mohamed, Amr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133062/ https://www.ncbi.nlm.nih.gov/pubmed/34026142 http://dx.doi.org/10.1002/ccr3.4099 |
Ejemplares similares
-
Thyroiditis: A Rare Manifestation of Enasidenib-Induced Differentiation Syndrome
por: Annamaraju, Pavan, et al.
Publicado: (2020) -
Sweet syndrome in a patient with Hidradenitis Suppurativa
por: Jain, Lakshay, et al.
Publicado: (2020) -
Concurrent Sweet’s Syndrome and Erythema Nodosum
por: Harris, Tracie, et al.
Publicado: (2010) -
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome
por: DiNardo, Courtney D., et al.
Publicado: (2022) -
Sweet Syndrome of the Hands?
por: Ortega, Irene Arevalo, et al.
Publicado: (2023)